The reasons of unfavorable outcomes of treatment in pulmonary tuberculosis patients in Kyrgyzstan

A. A. Toktogonova, N. K. Kurmanova, A. S. Alisherov (Bishkek, Kyrgyzstan)

Source: Annual Congress 2004 - Management of infection and tuberculous diseases I
Session: Management of infection and tuberculous diseases I
Session type: Thematic Poster Session
Number: 3938
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. A. Toktogonova, N. K. Kurmanova, A. S. Alisherov (Bishkek, Kyrgyzstan). The reasons of unfavorable outcomes of treatment in pulmonary tuberculosis patients in Kyrgyzstan. Eur Respir J 2004; 24: Suppl. 48, 3938

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019

Social determinants of non-successful treatment outcome in culture confirmed pulmonary TB patients in Poland
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007


Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004

The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001

On the efficiency of the long-term hospitalization treatment of patients with social problems with severe pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002

Reevaluation of treatment outcome of relapse and defaulter pulmonary tuberculosis cases
Source: Eur Respir J 2004; 24: Suppl. 48, 650s
Year: 2004

Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001

Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience
Source: Eur Respir J , 49 (3) 1602049; DOI: 10.1183/13993003.02049-2016
Year: 2017


The evaluation of the relapse or treatment interrupted pulmonary tuberculosis cases
Source: Eur Respir J 2006; 28: Suppl. 50, 21s
Year: 2006

Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002

Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009


Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012

The assessment of risk factors and treatment of pulmonary TB relapses
Source: Eur Respir J 2006; 28: Suppl. 50, 129s
Year: 2006

Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


Trend of delay treatment of patient and healthcare system in diagnosis and management of pulmonary tuberculosis in Iran
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

Significance of low cost pulmonary rehabilitation programme in post-pulmonary tubercular sequelae in patients of low socio-economic marginalized communities in India:Microbiological cure is the beginning and not the end of their illness.
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019


Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008


The efficiency of treatment of new cases of pulmonary TB in the hospital setting
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001

Characteristics  and therapeutic outcomes of pulmonary tuberculosis in the elderly .
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017